Fenofibrate lowers triglycerides and raises HDL (“good”) cholesterol. This dual action significantly benefits individuals with high triglycerides and low HDL, conditions associated with increased heart disease risk.
It works by activating PPAR-alpha receptors, influencing lipid metabolism. Specifically, it reduces the production of very-low-density lipoproteins (VLDLs), precursors to triglycerides. Simultaneously, it boosts HDL levels, contributing to cholesterol removal from the bloodstream.
Studies demonstrate a reduction in cardiovascular events in patients with high triglycerides and low HDL levels when treated with fenofibrate. However, individual responses vary. Your doctor will monitor your lipid profile regularly to assess treatment efficacy.
Remember, fenofibrate is a prescription medication. Do not start or stop taking it without your doctor’s guidance. They will assess your health status, consider other medications you are taking, and monitor potential side effects.
Common side effects include nausea, abdominal pain, and muscle aches. Rare but serious side effects include rhabdomyolysis (muscle breakdown). Report any unusual symptoms to your physician immediately.
Fenofibrate should not be combined with certain other medications. Your doctor will assess potential drug interactions before prescribing it. A healthy lifestyle, including diet and exercise, remains crucial for optimal cholesterol management.
